Clinicopathologic features of lung cancer patients harboring de novo EGFR T790M mutation

被引：1
|
作者：
Lee, Young Joo
Lee, Geon Kook
Lee, Yeon-Su
机构：
[1] Natl Canc Ctr, Goyang, South Korea
[2] Natl Canc Ctr, Div Convergence Technol, Goyang, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.8075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8075
引用
收藏
页数：1
相关论文
共 50 条
  • [41] High-throughput sequencing reveals distinct genetic features and clinical implications of NSCLC with de novo and acquired EGFR T790M mutation
    Tian, Panwen
    Ye Wang
    Wang, Weiya
    Li, Yalun
    Ke Wang
    Cheng, Xiaowei
    Yuan Tang
    Han Han-Zhang
    Ye, Junyi
    Chuai, Shannon
    Li, Weimin
    LUNG CANCER, 2018, 124 : 205 - 210
  • [42] Association between EGFR T790M status and progression patterns during initial EGFR-TKIs treatment in patients harboring EGFR mutation
    Oya, Y.
    Yoshida, T.
    Tanaka, K.
    Kuroda, H.
    Shimizu, J.
    Horio, Y.
    Sakao, Y.
    Inaba, Y.
    Hida, T.
    Yatabe, Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] A Case of a Patient Harboring an EGFR-T790M Mutation Positive in Squamous Cell Lung Cancer
    Runciman, T.
    Aliaga, C.
    Carracedo Gonzales, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1025 - S1026
  • [44] Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors
    Dogan, Izzet
    Khanmammadov, Nijat
    Paksoy, Nail
    Vatansever, Sezai
    Saip, Pinar
    Aydiner, Adnan
    EURASIAN JOURNAL OF PULMONOLOGY, 2023, 25 (01) : 27 - 32
  • [45] A patient with a lung adenosquamous carcinoma harboring a de novo T790M mutation and huge nonbacterial vegetative growths successfully treated with osimertinib: A case report
    Kim, So-yun
    Kim, Ka Eun
    Kim, Yoonjoo
    Chung, Chaeuk
    THORACIC CANCER, 2023, 14 (16) : 1530 - 1533
  • [46] A Case of a Patient Harboring an EGFR-T790M Mutation Positive in Squamous Cell Lung Cancer
    Runciman, T.
    Carracedo, C.
    Aliaga, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S179 - S179
  • [47] Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Hirano, Toshiyuki
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (01) : 31 - 38
  • [48] Safety and Efficacy of Osimertinib in Treating an EGFR-Mutant Lung Cancer Patient with a Germline EGFR T790M Mutation
    Ma, W.
    Gong, J.
    Shan, J.
    Lewis, D.
    Xiao, W.
    Hung, J.
    Moore, E. H.
    Zhang, Y.
    Mans, N. Z.
    Welborn, J.
    Lam, K. S.
    Li, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1863 - S1864
  • [49] Clinicopathological Characteristics of Non-small Cell Lung Cancer Patients With Primary Concomitant EGFR T790M Mutation
    Li, Hang
    Wang, Rui
    Hu, Haichuan
    Pan, Yunjian
    Wang, Lei
    Zhang, Yang
    Sun, Yihua
    Chen, Haiquan
    CHEST, 2014, 145 (03)
  • [50] Exploring the impact of EGFR T790M neighboring SNPs on ARMS-based T790M mutation assay
    Xu, Sanpeng
    Duan, Yaqi
    Lou, Liping
    Tang, Fengjuan
    Shou, Juan
    Wang, Guoping
    ONCOLOGY LETTERS, 2016, 12 (05) : 4238 - 4244
12345